Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Maltol (ST10-021) for Iron Deficiency Anaemia in Quiescent Ulcerative Colitis
NCT01340872Phase 3Completed
- Sponsor
- Shield Therapeutics plc
- Start
- Aug 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) comparing ST10 (Ferric Maltol) with Placebo (2 arms). Primary endpoint: Change in Haemoglobin Concentration From Baseline to Week 12. Started Aug 2011; status: completed.
02
Drugs
ferric maltol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01340872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01340872.